Physicians working with ICMs generally have a very heavy workload and false positive AF detections just add to this, as well making effective diagnosis more difficult.
BIOMONITOR IIIm provides answers to both of these issues. Minimizing unnecessary work by significantly reducing AF false positives1, and maximizing precision by consistently delivering clear, high definition ECGs. Helping physicians focus on the things that really matter.
With its breakthrough RhythmCheck algorithm, BIOMONITOR IIIm greatly reduces time-consuming ECG reviews of episodes falsely detected as atrial fibrillation
BIOMONITOR IIIm delivers clinically actionable high-definition ECGs
Patient-Centered Monitoring Experience
From injection to diagnosis, BIOMONITOR IIIm enhances workflow efficiency in every step of delivering a timely and accurate diagnosis
1. Performance of BIOMONITOR IIIm Ectopy Rejection Parameter in Patients with Ectopy. BIOTRONIK Data on File; 2. BIO|CONCEPT.BIOMONITOR III. BIOTRONIK Data on file; 3. Mariani JA et al. J Electrocardiol. 2020, 60.; 5. Piorkowski C, et al. Pacing and clinical electrophysiology : PACE. 2019; 6. BIOTRONIK AF Detect Analysis data on file 2019. PPV and sensitivity from analysis of BIOMONITOR III algorithm in patients with known AF from BIOTRONIK AF Detect study; 7. Afzal. Et al. Incidence of false-positive transmissions during remote rhythm monitoring with implantable loop recorders. Heart Rhythm 2020;17:75–80; 8. Deneke et al VOLUME 3, ISSUE 2, P152-159, APRIL 01, 2022 https://www.heartrhythmopen.com/article/S2666-5018(22)00044-7/fulltext; 9. Assaf A et al., Ann Noninvasive Electrocardiol., 2022